BACKGROUND: Current guidelines recommend treatment with one or more long-acting bronchodilators for patients with moderate or more severe chronic obstructive pulmonary disease (COPD). The authors investigated the approach of dual bronchodilation using indacaterol, a once-daily long-acting β(2) agoni...
Research Assistant
AI chat, annotations, notes & similar papers
No comments yet
Be the first to share your thoughts!